Rheumatoid arthritis is progressive, autoimmune inflammatory
chronic disorder which do not have curative treatment yet. Aryl and
hetero-aryl acids has maximum share of anti-inflammatory drugs in
the therapeutics today as non steroidal anti-inflammatory drugs
(NSAIDs). Benzimidazole moiety with heteroaryl and psudoacedic
nature is promising moiety for development of NSAIDs. In the
present project, synthesis, pharmacological evaluation, probable
mechanism of action and quantitative structure-activity
relationship (QSAR) of benzmidazole-2-carboxylic acids are
reported. The excellent efficacy and safety was observed for
benzimidaxole-2-carboxylic acid derivatives in laboratory animal
models of inflammation and rheumatoid arthritis without side-effect
of gastrointestinal disturbances. The reliving effects against pain
and fever in experimental animal models suggested promise as
potential NSAID.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!